Literature DB >> 17253466

Psychological therapies for generalised anxiety disorder.

V Hunot1, R Churchill, M Silva de Lima, V Teixeira.   

Abstract

BACKGROUND: Generalised anxiety disorder (GAD) is a highly prevalent condition, characterised by excessive worry or anxiety about everyday events and problems. The effectiveness and effectiveness of psychological therapies as a group has not yet been evaluated in the treatment of GAD.
OBJECTIVES: To examine the efficacy and acceptability of psychological therapies, categorised as cognitive behavioural therapy (CBT), psychodynamic therapy and supportive therapy, compared with treatment as usual/waiting list (TAU/WL) and compared with one another, for patients with GAD. SEARCH STRATEGY: We searched the Cochrane Depression, Anxiety & Neurosis Group (CCDAN) Controlled Trials Register and conducted supplementary searches of MEDLINE, PsycInfo, EMBASE, LILACS and controlledtrials.com in February 2006. We searched reference lists of retrieved articles, and contacted trial authors and experts in the field for information on ongoing/completed trials. SELECTION CRITERIA: Randomised and quasi-randomised controlled trials conducted in non-inpatient settings, involving adults aged 18-75 years with a primary diagnosis of GAD, assigned to a psychological therapy condition compared with TAU/WL or another psychological therapy. DATA COLLECTION AND ANALYSIS: Data on patients, interventions and outcomes were extracted by two review authors independently, and the methodological quality of each study was assessed. The primary outcome was anxiety reduction, based on a dichotomous measure of clinical response, using relative risk (RR), and on a continuous measure of symptom reduction, using the standardised mean difference (SMD), with 95% confidence intervals. MAIN
RESULTS: Twenty five studies (1305 participants) were included in the review, of which 22 studies (1060 participants) contributed data to meta-analyses. Based on thirteen studies, psychological therapies, all using a CBT approach, were more effective than TAU/WL in achieving clinical response at post-treatment (RR 0.63, 95%CI 0.55 to 0.73), and also in reducing anxiety, worry and depression symptoms. No studies conducted longer-term assessments of CBT against TAU/WL. Six studies compared CBT against supportive therapy (non-directive therapy and attention-placebo conditions). No significant difference in clinical response was indicated between CBT and supportive therapy at post-treatment (RR 0.86, 95%CI 0.70 to 1.06), however significant heterogeneity was indicated, which was partly explained by the number of therapy sessions. AUTHORS'
CONCLUSIONS: Psychological therapy based on CBT principles is effective in reducing anxiety symptoms for short-term treatment of GAD. The body of evidence comparing CBT with other psychological therapies is small and heterogeneous, which precludes drawing conclusions about which psychological therapy is more effective. Further studies examining non-CBT models are required to inform health care policy on the most appropriate forms of psychological therapy in treating GAD.

Entities:  

Mesh:

Year:  2007        PMID: 17253466      PMCID: PMC7025441          DOI: 10.1002/14651858.CD001848.pub4

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  76 in total

Review 1.  Treating generalised anxiety disorder.

Authors:  Alison Tonks
Journal:  BMJ       Date:  2003-03-29

2.  Imputing response rates from means and standard deviations in meta-analyses.

Authors:  Toshi A Furukawa; Andrea Cipriani; Corrado Barbui; Paolo Brambilla; Norio Watanabe
Journal:  Int Clin Psychopharmacol       Date:  2005-01       Impact factor: 1.659

3.  Recovery rates in generalized anxiety disorder following psychological therapy: an analysis of clinically significant change in the STAI-T across outcome studies since 1990.

Authors:  P L Fisher; R C Durham
Journal:  Psychol Med       Date:  1999-11       Impact factor: 7.723

4.  Cognitive restructuring treatment: a controlled trail with anxious patients.

Authors:  R Woodward; R B Jones
Journal:  Behav Res Ther       Date:  1980

5.  Brief standard self-rating for phobic patients.

Authors:  I M Marks; A M Mathews
Journal:  Behav Res Ther       Date:  1979

6.  The treatment of emotional disorders in general practice: psychological methods versus medication.

Authors:  D Gath; J Catalan
Journal:  J Psychosom Res       Date:  1986       Impact factor: 3.006

7.  A randomized trial of the effectiveness of cognitive-behavioral therapy and supportive counseling for anxiety symptoms in older adults.

Authors:  C Barrowclough; P King; J Colville; E Russell; A Burns; N Tarrier
Journal:  J Consult Clin Psychol       Date:  2001-10

8.  Treatment of generalised anxiety disorder with a short course of psychological therapy, combined with buspirone or placebo.

Authors:  Alyson J Bond; Janet Wingrove; H Valerie Curran; Malcolm H Lader
Journal:  J Affect Disord       Date:  2002-12       Impact factor: 4.839

9.  Cognitive-behavioral treatment of late-life generalized anxiety disorder.

Authors:  Melinda A Stanley; J Gayle Beck; Diane M Novy; Patricia M Averill; Alan C Swann; Gretchen J Diefenbach; Derek R Hopko
Journal:  J Consult Clin Psychol       Date:  2003-04

10.  Predicting outcome after treatment for generalised anxiety disorder.

Authors:  G Butler
Journal:  Behav Res Ther       Date:  1993-02
View more
  61 in total

Review 1.  Contextual conditioning in rats as an animal model for generalized anxiety disorder.

Authors:  Laura Luyten; Debora Vansteenwegen; Kris van Kuyck; Loes Gabriëls; Bart Nuttin
Journal:  Cogn Affect Behav Neurosci       Date:  2011-06       Impact factor: 3.282

2.  Management of Mental Health Disorders, Substance Use Disorders, and Suicide in Adults with Spinal Cord Injury: Clinical Practice Guideline for Healthcare Providers.

Authors:  Charles H Bombardier; Casey B Azuero; Jesse R Fann; Donald D Kautz; J Scott Richards; Sunil Sabharwal
Journal:  Top Spinal Cord Inj Rehabil       Date:  2021

Review 3.  Current considerations in the treatment of generalized anxiety disorder.

Authors:  Martin A Katzman
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

4.  Mental health treatment to reduce HIV transmission risk behavior: a positive prevention model.

Authors:  Kathleen J Sikkema; Melissa H Watt; Anya S Drabkin; Christina S Meade; Nathan B Hansen; Brian W Pence
Journal:  AIDS Behav       Date:  2010-04

Review 5.  Comparison of combined psycho- and pharmacotherapy with monotherapy in anxiety disorders: controversial viewpoints and clinical perspectives.

Authors:  P Zwanzger; J Diemer; B Jabs
Journal:  J Neural Transm (Vienna)       Date:  2008-09-23       Impact factor: 3.575

6.  The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses.

Authors:  Stefan G Hofmann; Anu Asnaani; Imke J J Vonk; Alice T Sawyer; Angela Fang
Journal:  Cognit Ther Res       Date:  2012-07-31

Review 7.  The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders.

Authors:  Baptiste Pignon; Chloé Tezenas du Montcel; Louise Carton; Antoine Pelissolo
Journal:  Curr Psychiatry Rep       Date:  2017-11-07       Impact factor: 5.285

8.  Stepped care for depression and anxiety: from primary care to specialized mental health care: a randomised controlled trial testing the effectiveness of a stepped care program among primary care patients with mood or anxiety disorders.

Authors:  Wike Seekles; Annemieke van Straten; Aartjan Beekman; Harm van Marwijk; Pim Cuijpers
Journal:  BMC Health Serv Res       Date:  2009-06-05       Impact factor: 2.655

Review 9.  Adherence in internet interventions for anxiety and depression.

Authors:  Helen Christensen; Kathleen M Griffiths; Louise Farrer
Journal:  J Med Internet Res       Date:  2009-04-24       Impact factor: 5.428

10.  Psychoeducation for depression, anxiety and psychological distress: a meta-analysis.

Authors:  Tara Donker; Kathleen M Griffiths; Pim Cuijpers; Helen Christensen
Journal:  BMC Med       Date:  2009-12-16       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.